Clinical trial · Observational
Evaluation of MRI for Prostate Cancer
Evaluation of the Potential of Endorectal MRI for the Staging and Recurrence of Prostate Cancer
NCT00930748CI-TRIAL-00005100terminatedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): The MRI company forbidded additional scans with endorectal colil in this machine
Summary
Brief summary (as posted)
The objective of this study is to evaluate imaging quality and correlation with histopathology in prostate cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostatic Neoplasms | Prostate Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| MR imaging with endorectal coil | Device | — | UNRESOLVED |
| MRI with endo-rectal coil | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- • MRI and pathology correlation
- timeFrame
- 2 years
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * Age of patients: up to 80 years. * Men scheduled for radical prostatectomy due to prostate cancer or men post radical prostatectomy with suspicion of recurrence. * Patients who are able and willing to give consent and able to have an MRI examination. Exclusion Criteria: * Contraindications to MRI including: claustrophobia, weight over 120 kg, implanted ferromagnetic materials or foreign objects, and known intolerance to the MRI contrast agent (e.g. Gadolinium or Dotarem) * Individuals who are not able or willing to tolerate the required prolonged stationary supine position during imaging (approximately 1 hr.) * Any rectal pathology preventing probe insertion, (as active proctitis, active ulcerative colitis, fissure ani) * Any spinal pathology that prohibits maintaining supine position for an hour * Patients with documented myocardial infarction within one month of protocol entry, and patients with cardiac pacemakers * Severe cerebrovascular disease (multiple CVA or CVA within 6 months)
References
Publications (0)
Data not yet available
No reference posted for this study.